MedTrace Logo

Characterization of the Melanoma-Specific Immune Response

NCT00368615 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-01-23

No results posted yet for this study

Summary

The aim of this study is to study T-cells. Blood will be collected and the samples will be used to generate T cell clones. Two separate blood draws will be required at the maximum.

Conditions

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Emanual Maverakis, M.D. · University of California, Davis

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00368615 on ClinicalTrials.gov